Interleukin-21: a critical regulator of the balance between effector and regulatory T-cell responses

scientific article

Interleukin-21: a critical regulator of the balance between effector and regulatory T-cell responses is …
instance of (P31):
scholarly articleQ13442814
review articleQ7318358

External links are
P356DOI10.1016/J.IT.2008.02.008
P698PubMed publication ID18440864

P2093author name stringFrancesco Pallone
Giovanni Monteleone
Thomas T MacDonald
P2860cites workReciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cellsQ27860460
P433issue6
P921main subjectinterleukinsQ194908
P304page(s)290-294
P577publication date2008-04-25
P1433published inTrends in ImmunologyQ15265730
P1476titleInterleukin-21: a critical regulator of the balance between effector and regulatory T-cell responses
P478volume29

Reverse relations

cites work (P2860)
Q49841249A pilot study on the characteristics of circulating T follicular helper cells in liver transplant recipients
Q36907647A regulatory effect of IL-21 on T follicular helper-like cell and B cell in rheumatoid arthritis
Q42246581Analysis of the mucosal immune responses induced by single and trickle infections with the bovine abomasal nematode Ostertagia ostertagi
Q51052885Anti-tumour necrosis factor therapy enhances mucosal healing through down-regulation of interleukin-21 expression and T helper type 17 cell infiltration in Crohn's disease.
Q45738584Autocrine IL-21 stimulation is involved in the maintenance of constitutive STAT3 activation in Sézary syndrome
Q35669245Blocking IL-21 signaling ameliorates xenogeneic GVHD induced by human lymphocytes
Q39283252CREM Alpha Enhances IL-21 Production in T Cells In Vivo and In Vitro
Q30436283Cutting edge: genetic characterization of IFN-producing killer dendritic cells.
Q37353862Detecting shared pathogenesis from the shared genetics of immune-related diseases
Q37977126Direct and indirect regulatory mechanisms in TH17 cell differentiation and functions
Q46779685Donor Th17 cells and IL-21 may contribute to the development of chronic graft-versus-host disease after allogeneic transplantation.
Q36305622Elevated expression of interleukin-21 and its correlation to T-cell subpopulation in patients with ulcerative colitis
Q34547617Exclusion of IL-21 in the pathogenesis of OVA-induced asthma in mice.
Q46022940Expansion of regulatory T cells from umbilical cord blood and adult peripheral blood CD4(+)CD25 (+) T cells.
Q39001895Exploring the IL-21-STAT3 axis as therapeutic target for Sézary syndrome.
Q26769670Genetic Factors in Systemic Lupus Erythematosus: Contribution to Disease Phenotype
Q37866624HIV-specific CD4 T cells and immune control of viral replication
Q34320455Human RORγt+ TH17 cells preferentially differentiate from naive FOXP3+Treg in the presence of lineage-specific polarizing factors
Q46309160IL-15 positively regulates IL-21 production in celiac disease mucosa.
Q38243870IL-21 as a therapeutic target in inflammatory disorders
Q37484523IL-21 blockade reduces graft-versus-host disease mortality by supporting inducible T regulatory cell generation
Q35840846Impact of interleukin-21 in the pathogenesis of primary Sjögren's syndrome: increased serum levels of interleukin-21 and its expression in the labial salivary glands
Q26823647Inflammatory cytokines in systemic lupus erythematosus
Q54333384Interleukin-21 expression and its association with proinflammatory cytokines in untreated chronic periodontitis patients.
Q41549665Interleukin-21 gene polymorphism rs2221903 is associated with disease activity in patients with rheumatoid arthritis
Q42279852Interleukin-21 mediates hepatitis B virus-associated liver cirrhosis by activating hepatic stellate cells
Q34002864Interleukin-21: a new mediator of inflammation in systemic lupus erythematosus
Q58434904Involvement of interleukin-21 in the epidermal hyperplasia of psoriasis
Q41200516Involvement of interleukin-21 in the pathophysiology of aplastic anemia
Q39590657Involvement of the Interleukin-23/Interleukin-17 Axis in Chronic Hepatitis C Virus Infection and Its Treatment Responses
Q38125275Keeping the bowel regular: the emerging role of Treg as a therapeutic target in inflammatory bowel disease.
Q95642187Novel Therapeutic Options for People with Ulcerative Colitis: An Update on Recent Developments with Janus Kinase (JAK) Inhibitors
Q35596715Phenotypic associations of genetic susceptibility loci in systemic lupus erythematosus
Q37845585Progesterone activates multiple innate immune pathways in Chlamydia trachomatis-infected endocervical cells.
Q37789387Psoriasis: from pathogenesis to novel therapeutic approaches
Q64271648Relationships Between Phenotype and Function of Blood CD4+ T-Cells and Ascending Thoracic Aortic Aneurysm: an Experimental Study
Q46987803Role of IL-21 in inflammatory bowel disease
Q55263188Role of interleukin-21 and interleukin-21 receptor polymorphisms in the treatment of HBeAg-positive chronic hepatitis B patients with peginterferon.
Q37164125Surveillance of antigen-presenting cells by CD4+ CD25+ regulatory T cells in autoimmunity: immunopathogenesis and therapeutic implications.
Q37851522Targeting interleukin-21 in inflammatory diseases
Q38810926Tertiary lymphoid structures, drivers of the anti-tumor responses in human cancers
Q36520827Th17 cell enhances CD8 T-cell cytotoxicity via IL-21 production in emphysema mice
Q35327827Th17 cells and transplant acceptance
Q21284677Th17 cells in autoimmune and infectious diseases
Q35116966The Role of Th17 in Neuroimmune Disorders: A Target for CAM Therapy. Part III
Q37557971The Role of Th17 in Neuroimmune Disorders: Target for CAM Therapy. Part I
Q51152901The circadian gene Arntl2 on distal mouse chromosome 6 controls thymocyte apoptosis.
Q41892056The expression levels of transcription factors T-bet, GATA-3, RORγt and FOXP3 in peripheral blood lymphocyte (PBL) of patients with liver cancer and their significance

Search more.